Defects in GnRH Neuron Migration/Development and Hypothalamic-Pituitary Signaling Impact Clinical Variability of Kallmann Syndrome

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2021 Jul 2

PMID 34198905

Citations 4

Authors

Malgorzata Kaluzna

Bartlomiej Budny

Michal Rabijewski

Jaroslaw Kaluzny

Agnieszka Dubiel

Malgorzata Trofimiuk-Muldner

Elzbieta Wrotkowska

Alicja Hubalewska-Dydejczyk

Marek Ruchala

Katarzyna Ziemnicka

Affiliations

Soon will be listed here.

Abstract

Kallmann syndrome (KS) is a combination of isolated hypogonadotropic hypogonadism (IHH) with olfactory dysfunction, representing a heterogeneous disorder with a broad phenotypic spectrum. The genetic background of KS has not yet been fully established. This study was conducted on 46 Polish KS subjects (41 males, 5 females; average age: 29 years old). The studied KS patients were screened for defects in a 38-gene panel with next-generation sequencing (NGS) technology. The analysis revealed 27 pathogenic and likely pathogenic (P/LP) variants, and 21 variants of uncertain significance (VUS). The P/LP variants were detected in 20 patients (43.5%). The prevalence of oligogenic P/LP defects in selected genes among KS patients was 26% (12/46), whereas the co-occurrence of other variants was detected in 43% (20 probands). The examined KS patients showed substantial genotypic and phenotypic variability. A marked difference in non-reproductive phenotypes, involving defects in genes responsible for GnRH neuron development/migration and genes contributing to pituitary development and signaling, was observed. A comprehensive gene panel for IHH testing enabled the detection of clinically relevant variants in the majority of KS patients, which makes targeted NGS an effective molecular tool. The significance of oligogenicity and the high incidence of alterations in selected genes should be further elucidated.

Citing Articles

Novel and recurrent genetic variants associated with male and female infertility.

Jankowska K, Kutkowska-Kazmierczak A, Slusarczyk K, Domaszewicz A, Duk K, Wolski J J Appl Genet. 2025; .

PMID: 39809967 DOI: 10.1007/s13353-024-00935-3.

Magnetic resonance imaging does not distinguish Kallmann syndrome from normosmic isolated hypogonadotropic hypogonadism.

Kaluzna M, Katulska K, Ziemnicka K, Kompf P, Budny B, Komarnicki P Endocr Connect. 2024; 14(2).

PMID: 39719010 PMC: 11770403. DOI: 10.1530/EC-24-0437.

Variety of genetic defects in GnRH and hypothalamic-pituitary signaling and development in normosmic patients with IHH.

Kaluzna M, Budny B, Rabijewski M, Dubiel A, Trofimiuk-Muldner M, Szutkowski K Front Endocrinol (Lausanne). 2024; 15:1396805.

PMID: 39010903 PMC: 11246878. DOI: 10.3389/fendo.2024.1396805.

Digenic and inheritance Unveils phenotypic variability in a family mainly presenting with hypogonadotropic hypogonadism.

Wang T, Ren W, Fu F, Wang H, Li Y, Duan J Heliyon. 2023; 10(1):e23272.

PMID: 38148819 PMC: 10750161. DOI: 10.1016/j.heliyon.2023.e23272.

Convergent biological pathways underlying the Kallmann syndrome-linked genes Hs6st1 and Fgfr1.

Moon S, Zhao Y Hum Mol Genet. 2022; 31(24):4207-4216.

PMID: 35899427 PMC: 9759331. DOI: 10.1093/hmg/ddac172.

References

Xu N, Kim H, Bhagavath B, Cho S, Lee J, Ha K . Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011; 95(5):1613-20.e1-7. PMC: 3888818. DOI: 10.1016/j.fertnstert.2011.01.010. View

Tickotsky N, Moskovitz M . Renal agenesis in Kallmann syndrome: a network approach. Ann Hum Genet. 2014; 78(6):424-33. DOI: 10.1111/ahg.12079. View

Reuter M, Tawamie H, Buchert R, Gebril O, Froukh T, Thiel C . Diagnostic Yield and Novel Candidate Genes by Exome Sequencing in 152 Consanguineous Families With Neurodevelopmental Disorders. JAMA Psychiatry. 2017; 74(3):293-299. DOI: 10.1001/jamapsychiatry.2016.3798. View

Pingault V, Bodereau V, Baral V, Marcos S, Watanabe Y, Chaoui A . Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet. 2013; 92(5):707-24. PMC: 3644631. DOI: 10.1016/j.ajhg.2013.03.024. View

Vaaralahti K, Tommiska J, Tillmann V, Liivak N, Kansakoski J, Laitinen E . De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss. Pediatr Res. 2014; 76(1):115-6. DOI: 10.1038/pr.2014.60. View

Pierzchlewska M, Robaczyk M, Vogel I . Induction of puberty with human chorionic gonadotropin (hCG) followed by reversal of hypogonadotropic hypogonadism in Kallmann syndrome. Endokrynol Pol. 2017; 68(6):692-696. DOI: 10.5603/EP.a2017.0059. View

Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes F, Hughes V . Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007; 357(9):863-73. DOI: 10.1056/NEJMoa066494. View

Elsberg C, Levy I, Brewer E . A NEW METHOD FOR TESTING THE SENSE OF SMELL AND FOR THE ESTABLISHMENT OF OLFACTORY VALUES OF ODOROUS SUBSTANCES. Science. 1936; 83(2148):211-2. DOI: 10.1126/science.83.2148.211. View

Quaynor S, Kim H, Cappello E, Williams T, Chorich L, Bick D . The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011; 96(6):1424-1430.e6. PMC: 3573697. DOI: 10.1016/j.fertnstert.2011.09.046. View

10.

Asakura Y, Muroya K, Hanakawa J, Sato T, Aida N, Narumi S . Combined pituitary hormone deficiency with unique pituitary dysplasia and morning glory syndrome related to a heterozygous PROKR2 mutation. Clin Pediatr Endocrinol. 2015; 24(1):27-32. PMC: 4322290. DOI: 10.1297/cpe.24.27. View

11.

Bianco S, Kaiser U . The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009; 5(10):569-76. PMC: 2864719. DOI: 10.1038/nrendo.2009.177. View

12.

Cangiano B, Duminuco P, Vezzoli V, Guizzardi F, Chiodini I, Corona G . Evidence for a Common Genetic Origin of Classic and Milder Adult-Onset Forms of Isolated Hypogonadotropic Hypogonadism. J Clin Med. 2019; 8(1). PMC: 6352096. DOI: 10.3390/jcm8010126. View

13.

Bouligand J, Ghervan C, Tello J, Brailly-Tabard S, Salenave S, Chanson P . Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med. 2009; 360(26):2742-8. DOI: 10.1056/NEJMoa0900136. View

14.

Turan I, Hutchins B, Hacihamdioglu B, Kotan L, Gurbuz F, Ulubay A . CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism. J Clin Endocrinol Metab. 2017; 102(6):1816-1825. PMC: 5470764. DOI: 10.1210/jc.2016-3391. View

15.

Cho H, Shan Y, Whittington N, Wray S . Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome. Front Cell Dev Biol. 2019; 7:121. PMC: 6637222. DOI: 10.3389/fcell.2019.00121. View

16.

Dalton P, Mennella J, Cowart B, Maute C, Pribitkin E, Reilly J . Evaluating the prevalence of olfactory dysfunction in a pediatric population. Ann N Y Acad Sci. 2009; 1170:537-42. PMC: 3046421. DOI: 10.1111/j.1749-6632.2009.03919.x. View

17.

Yang Z, Lasker K, Schneidman-Duhovny D, Webb B, Huang C, Pettersen E . UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J Struct Biol. 2011; 179(3):269-78. PMC: 3410985. DOI: 10.1016/j.jsb.2011.09.006. View

18.

Miraoui H, Dwyer A, Sykiotis G, Plummer L, Chung W, Feng B . Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013; 92(5):725-43. PMC: 3644636. DOI: 10.1016/j.ajhg.2013.04.008. View

19.

Rojek A, Obara-Moszynska M, Malecka E, Slomko-Jozwiak M, Niedziela M . NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding. J Appl Genet. 2013; 54(2):225-30. DOI: 10.1007/s13353-013-0135-3. View

20.

Butz H, Nyiro G, Kurucz P, Liko I, Patocs A . Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice. Hum Genet. 2020; 140(1):113-134. PMC: 7864839. DOI: 10.1007/s00439-020-02148-0. View